NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 64 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $17,000 | -41.4% | 18,452 | -15.9% | 0.00% | – |
| Q4 2015 | $29,000 | -12.1% | 21,942 | +52.7% | 0.00% | – |
| Q3 2015 | $33,000 | +6.5% | 14,368 | -24.5% | 0.00% | – |
| Q2 2015 | $31,000 | -32.6% | 19,021 | -34.7% | 0.00% | -100.0% |
| Q1 2015 | $46,000 | -24.6% | 29,120 | -9.6% | 0.00% | 0.0% |
| Q4 2014 | $61,000 | -22.8% | 32,224 | -46.0% | 0.00% | 0.0% |
| Q3 2014 | $79,000 | -26.9% | 59,727 | -18.5% | 0.00% | 0.0% |
| Q2 2014 | $108,000 | -51.8% | 73,256 | -39.5% | 0.00% | -66.7% |
| Q1 2014 | $224,000 | +12.0% | 121,069 | +60.1% | 0.00% | -40.0% |
| Q3 2013 | $200,000 | +7.5% | 75,607 | +8.7% | 0.01% | +25.0% |
| Q2 2013 | $186,000 | – | 69,541 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Platinum Management (NY) LLC | 15,575,946 | $14,711,000 | 89.51% |
| Financial Advisory Group | 10,000 | $356,000 | 0.17% |
| COMMERZBANK AKTIENGESELLSCHAFT /FI | 6,704,067 | $6,332,000 | 0.05% |
| LifePlan Financial Group, Inc | 28,810 | $27,000 | 0.02% |
| Greenwich Wealth Management LLC | 65,066 | $61,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 649,880 | $614,000 | 0.01% |
| LYNCH & ASSOCIATES/IN | 18,000 | $17,000 | 0.01% |
| SII INVESTMENTS INC/WI | 90,315 | $86,000 | 0.01% |
| Stratos Wealth Partners, LTD. | 42,535 | $40,000 | 0.00% |
| SVB WEALTH LLC | 46,262 | $44,000 | 0.00% |